chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a medical assistant concerning her 12 year old daughter with no pertinent medical history reported and no known drug allergies, who on 06-APR-2009 was vaccinated in the left arm with GARDASIL (dose and route not reported, lot number 661841/0653X). Concomitant therapy included MENACTRA (administered in the left arm) and ENGERIX-B (administered in the right arm). The medical assistant reported that six to eight hours after vaccination, the patient experienced injection site pain, injection site swelling, injection site redness and the site was ridged. The patient also experienced headache, fever, nausea, some dizziness and loss of appetite. The medical assistant stated that he has been treating the patient, and she still has not fully recovered. " No labs studies were performed. The patient sought unspecified medical attention. Additional information has been requested.
Patient states she is in a lot of pain in her left arm and that she can not even raise her arm up.  In addition, she has  bruising, fever, rash and feels sick.
Fever temp 102, chills, diaphoresis, fatigue, decreased appetite, polydipsia
large raised area on left arm.; Very itchy oval 2 3/4 inches by 2 inches; secondary circle of red/ red firm spot on arm about 1 inch in diameter; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via an unspecified route of administration in the left arm on 05Mar2021 at 11:00 (at the age of 72-years-old) as single dose for COVID-19 immunisation. The patients medical history was reported as none and had an allergy to pethidine hydrochloride (DEMEROL). The patient took unspecified concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 12Mar2021, the patient experienced large raised area on left arm, very itchy oval 2 3/4 inches by 2 inches. On unknown date in Mar2021, the patient experienced a secondary red circle but eventually swelling and itching had stopped. The patient still had a red firm spot on arm about 1 inch in diameter and there were no other ill effects. The patient had applied BENADRYL cream as treatment for reported event. The adverse events resulted in emergency room/department or urgent care visit. The clinical outcome of event red firm spot was not resolved while that of raised area on left arm and Itchy were resolved on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Blood pressure went high  200/107; received the third dose of BNT162B2; received the third dose of BNT162B2; This is a spontaneous report from a contactable consumer (patient's husband). An 81-year-old female patient received the third dose of BNT162B2 via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. Medical history and concomitant medication were not reported. The patient previously received the second dose and the first dose of BNT162B2 both via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. On an unspecified date, the patient experienced blood pressure went high 200/107 mmHg. The outcome of events was unknown.  The lot number for BNT162B2, was not provided and will be requested during follow up.
Unknowingly gave third dose in two dose series. First dose 06/27/22 Second dose 08/02/22 Third dose 08/30/33  Followed up with pt, no adverse effects, no treatment.
56 yo female c/o of dizziness after receiving COVID 19 vaccine. States just feeling a little dizzy ; denies any other  symptoms.  Pt escorted in exam room. Sitting up on exam table. Drinking water. Reported has eaten recently. States has "white coat"  syndrome  9:02 -VS taken via vital sign machine. BP 177/111;(left arm)  P-93;  VS taken on opposite arm (right) using manual BP cuff. 174/110.  Pt stated feeling tingling in lips now . Denies any other symptom other than dizziness. No SOB, HA, CP, wheezing, angioedema noted. BP repeated 9:07- BP 179/111;P-110. Pt c/o now of feeling of  knot in throat and reported had reaction to flu vaccines and was given epi pen injection. Pt escorted by corpsman via wheelchair with epi pen to ED for further evaluation.
Varivax administered 4/15/08 at 4:30pm.  Mom called on 4/16/08 and stated patient had a reaction to the vaccine.  Her right arm at injection site, upper outer arm had soreness and "silver dollar" sized red area with puffiness.  Mom instructed to call when resolved.  Resolved after 3 days.
11-04-09 DTaP indicated and ordered by physician - BOOSTRIX given in error. Noted error when chart reviewed. Local Health dept consulted - recommended contacting manufacturer. Spoke with representative at GSK: valid dose, no need to report  - No serious adverse events - Reported in study of this type of situation.
Patient was given the vaccine accidentally 27 hours after it was removed from the fridge instead of before 24
I82.402 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 9/1/2022 SHORTNESS OF BREATH
Patient reported feeling lightheaded about 3 minutes after the vaccine. After sitting down, patient had a seizure that lasted about 1 minute. Patient regained consciousness and felt tingling sensation. He had no history of seizures.
That day, light headed ness and heart palpitations.  Heart palpitations for short time only but felt periodically over the next few days.  June 11, lower left led swelled and painful and shortness of breath.  June 14, went to ER.  They found multiple blood clots in upper thigh, behind knee and lower left leg.  They also found approximately 20 clots in the lungs and administered Heparin drip and I was impatient.  They put me on Eliquis and released me the next day.  Now convalescing at my daughter?s house.  Diagnosis. Acute Deep Vein Thromboses and Pulmonary Embolism bilateral.
Information was received from a lawyer on 22-FEB-2019 regarding a case in litigation concerning a female patient, medical history not provided. The patient was prescribed ZOSTAVAX by a healthcare provider for the long term prevention of shingles and zoster related conditions. On or about 01-JUN-2015, at age 69, the patient was administered the ZOSTAVAX vaccine by a pharmacist at a pharmacy.  On an unspecified date the patient was treated by a physician for the following injuries resulting from ZOSTAVAX use: shingles. Outcome was not provided. Additional information has been requested.
PATIENT REPORTED ARM PAIN AT INJECTION SITE THAT LASTED ABOUT 4 WEEKS. SHE SAID IT KEEPS GETTING BETTER, BUT IS STILL SORE AT TIMES. PATIENT SAID SHE WENT TO HER DR WHO SAID IT LOOKS LIKE WE GAVE INJECTION INTO THE LOWER DELTOID, BUT INTO A NERVE FIBER.
Symp. warm to touch / sharp pains and movement  of right arm. Given a ice pack in school; some Ibuprofen at home.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021 at 3:44 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Apr-2021 at 3:44 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 67.44 for dose administered on 15-Apr-2021. No concomitant medications were reported.  Batch number 044B21A administered on 15-Apr-2021 underwent temperature excursion with temperature of 34 degrees Fahrenheit at 09:00 AM. This vial was moved to fridge on 06-Apr-2021 and beyond use date for the vial was reported as 09-May-2021. Product moved to clinic on 15-Apr-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  No treatment medications were reported.
Localized swelling, redness and warmth with intense pain at injection site. Took ibuprofen and Benadryl which helped relieved symptoms
45 minutes post vax, the pt experienced itching on arm. 1 hour post vax, the pt experienced whole body itching, red flushing. Treated with Benadryl. 4 hours later was repeated because of symptoms.
19JAN94 AM devel pruritic, indurated rash on feet lasted only 1 day;
C/O of (RD) redness and swelling x 1 day. Denies pain/discomfort/fever T: 97.8 (Axill). NP provider Rx BENADRYL (child) 1/2 tsp Q 6 H PRN, TYLENOL 1 tsp Q 6-8 H PRN. F/U tomorrow; if worse ER hospital. 12/18/13 pt came in for F/U much better color lighter.
I21.4 ACUTE NON ST ELEVATION MI 7/10/2021 ATRIAL FIBRILLATION W RAPID VENTRICULAR RESPONSE I21.4 ACUTE NON ST ELEVATION MI 7/10/2021 ATRIAL FIBRILLATION W RAPID VENTRICULAR RESPONSE I21.4 ACUTE NON ST ELEVATION MI 7/10/2021 ALTERED MENTAL STATUS, UNSPECIFIED I21.4 ACUTE NON ST ELEVATION MI 7/10/2021 ADENOCARCINOMA, RIGHT LUNG MIDDLE LOBE
Information has been received from a health professional concerning a patient who was vaccinated subcutaneously with a 0.5ml dose of varicella virus vaccine live (Oka/Merck). Subsequently, the patient experienced chicken pox. It was reported that the case was mild with less than 50 lesions and the child is recovering. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Noticeable, but minimal pain at the injection site for about 36 hours. Minor fatigue through 36 hours. No other events.
Pt. received Moderna as first dose; he is received Pfizer as second dose today.
On 3/15/01, pt's mom phoned to state that the pt's right leg was swollen to twice it's normal size, from above the knee to the groin. No fever or complaint of pain while walking or playing. Mom is using Tylenol every 4 hours. Advised to continue with Tylenol and use cool compresses. Call MD if needed. On 3/16/01, telephone call to Mom and she states swelling is resolved and child playing.
46-year-old female presents to the emergency department for evaluation of a suspected allergic reaction.  The patient states that she received the COVID-19 vaccine on Saturday.  She states that later that evening she started having intermittent episodes of muscle twitching.  States that she 1st noticed it in her face with some associated facial numbness.  Reports that she was also having episodes in her arms, legs and feet.  The patient reports that she treated her symptoms with Benadryl and Motrin with no improvement.  Reports that she had difficulty sleeping last night and continued symptoms today so came to the emergency department for further evaluation.  The patient states that she has multiple allergies and was initially hesitant to get the COVID-19 vaccine because of fever that she would have a reaction to it.  The patient states that along with the intermittent episodes of twitching she has also had chest pain that she describes as intermittent nonradiating and nonexertional 6/10 pain.  She denies fevers, chills, nausea, vomiting, diarrhea, sick contacts, recent travel, shortness of breath and diaphoresis.
Not feeling good; Feeling pain in stomach and wants to throw up; Feeling pain in stomach and wants to throw up; Dizzy; Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A female patient received bnt162b2 (BNT162B2), administration date 26May2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious) with onset 27May2021, outcome "unknown", described as "Not feeling good"; ABDOMINAL PAIN UPPER (non-serious), VOMITING (non-serious) all with onset May2021, outcome "unknown" and all described as "Feeling pain in stomach and wants to throw up"; DIZZINESS (non-serious) with onset May2021, outcome "unknown", described as "Dizzy"; HEADACHE (non-serious) with onset May2021, outcome "unknown", described as "Headache".  Additional information: Reported stated that she don't know if she was at right firm. She was calling because her daughter (consumer) took Pfizer first doses vaccine yesterday but she was not feeling good today. She was feeling pain in stomach and feeling dizzy. She wants to throw up, so she wants to make sure, was it normal or need to go to the Doctor.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient received PPSV23 on 9/19/19 she reported having swelling later in the evening with redness and warmth.  She reported to the office on 09/20/2019 and the provider checked her arm and told her to take Benadryl non-drowsy and to continue using cold compresses.  She presented to the office again on 09/23/2019 showing us her arm which showed improvement.
Expired vaccine used; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 63-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 15-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that on 15-Oct-2021, the patient received vaccine with expiration date 09-Oct-2021.  No concomitant medications was reported. No treatment drug details was reported.
pins and needles in throat moved to tongue, roof of mouth,  and lips. Did not extend to the scalding sensation she got before, and was a  shorter duration than the first time.  also had fevers on and off the next day (Tmax 101F), restless legs for 12 hrs.
10/17/2005 at 8:00 pt called to report symptoms of headache, fever, diarrhea, muscle aches started Saturday 10/15/2005 after receiving MMR on 10/14/2005. Instructed pt to see PCP for documentation of vaccine allergy if found. 10/17/2005 at 12:00 pt called to say PCP says all symptoms are those of adverse reaction in adults receiving MMR. Advised pt to bring note from PCP documenting history of allergy. Also let pt know that I would complete VAERS report today.
Pain around injection site much worse than 1st 2 days after shot which limited use of arm, large lump and localized swelling near site, hives- like redness about 2inches diameter along with smaller spots, hot and itchy. Better with topical hydrocortisone and oral Benadryl after 2 days. Residual muscle pain.
Received 0.25ml of Bivalent booster instead of 0.5 ml; No Adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (Received 0.25ml of Bivalent booster instead of 0.5 ml) and NO ADVERSE EVENT (No Adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Received 0.25ml of Bivalent booster instead of 0.5 ml) and NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Received 0.25ml of Bivalent booster instead of 0.5 ml) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Received 0.25ml of Bivalent booster instead of 0.5 ml).    No concomitant medication was reported.    Vaccination date was reported as 01-SEP-2022 to 26-OCT-2022. No treatment information was reported. This case contains information for the 1st of 20 patients described by the reporter.
My testosterone levels have been floating in the low/medium range for a couple years now. After that vaccination, I started feeling more lethargic, had more difficulty focusing, my libido decreased and I felt weak. My doctor called for another testosterone test and it came back much lower . I had another one after that which also came back  low. It was a sudden drop.
Sore arm then 24 hours later muscle and joint pains lasting 7 hours with 1.5 degree temperature above normal. Then a day later, the same reaction, lasting 8 hours. Arm is red, puffy, and warm and itches.
Pt stated itching after injection, came to pharmacy next day with redness and swelling at injection site, no complaints of trouble breathing.
Dizziness, Headache, Fever, Rash, HYPERtension, chills, fatigue, nasal congestion, L sided facial tingling Narrative:  MRI performed to r/u CVA in ER
his wife was vaccinated but still got CoVid; his wife was vaccinated but still got Covid; This is a spontaneous report from a program via a non-contactable other, HCP reported for a female patient. A female patient of an unspecified age received a dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as unknown, a single dose for COVID-19 immunization. The reporter stated the patient was vaccinated but still got COVID on an unspecified date. The reporter went on to express wishes that hopes everyone from Pfizer gets COVID and wondered how we could sleep with ourselves for inventing such a terrible vaccine and went on with some profanities and hung up. The patient underwent lab test and procedure included COVID with result still got covid on an unspecified date. Outcome of the events was unknown.  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained. Sender's Comments: As there is limited information in the case provided, the causal association between the event Covid 19 and the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.
Systemic: Allergic: Difficulty Breathing-Mild, Systemic: SOB reported next day-Mild
Patient reports unilateral erythema, swelling, and itching in her left deltoid region that began 1-2 days post injection. Patient was advised to use cold compress and diphenhydramine.
Tachycardia; This case was reported by a other health professional via call center representative and described the occurrence of tachycardia in a 56-year-old male patient who received Herpes zoster (Shingrix) (batch number 4257F, expiry date 11th September 2021) for prophylaxis.   The patient's past medical history included atrial fibrillation.   On 6th May 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 7th May 2019, 1 days after receiving Shingrix, the patient experienced tachycardia. On an unknown date, the outcome of the tachycardia was recovered/resolved.   The reporter considered the tachycardia to be unrelated to Shingrix.  Additional information received were as follows: The medical assistant on the line to reported that the patient received their first Shingrix and went to the urgent care and had an EKG (Electrocardiogram), the next day and was diagnosed with tachycardia with a heart rate that went up to 104 beats per minutes. The patient's heart rate was fast but otherwise he was feeling fine. Exactly when the events started or resolved were unknown. The medical assistant reported that the MD seem to thought that the tachycaardia may not had been due to Shingrix, as patient had a history of atrial fibrillation.
PFIZER TEMPERATURE EXCURSION. THE VACCINE WAS IN THE FREEZER FOR 3 WEEKS THEN IT WAS MOVED TO THE FRIDGE FOR A WEEK. AFTER THAT IT WAS ADMINSTERED TO  THE PATIENT
Tingling and loss of feelings overnight in both legs. Treated with corticosterioids.
Rapid heart beat, burning in the center chest, right side and left side, sharp pinch in center and left side of chest, lest arm pain, pain in back, shortness of breath.  Hurts to breath, irregular hear beat, beat feels fast and deep, feels tightness in throat. Light headed ness and at time body feels light headed Treatment ibuprofen didn?t work colchicine. Helping symptoms still present
Headache, dizziness, muscle aches (head, neck, shoulders). Onset 5 minutes after vaccination. Symptoms resolved within 30 minutes.
Patient received vaccination and went out front to wait for the recommended  15 minutes.  A few minutes later they fainted.  911 was called and they were attended to by a Pharmacist.  Patient was conscious.  Waited for Paramedics.  They ended up taking him away. I was not told anything by Paramedics.